/Companies

Biorce

9 known investors

Find your way into Biorce

Sign up to see every warm intro you have to Biorce

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Biorce team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Aika is an operating system that uses AI and automation to orchestrate clinical trial development end-to-end, helping organizations accelerate protocol creation, prevent amendments, and interpret complex datasets across all stages of trial development.

Founders & leadership

PCPedro Coelho
Pedro CoelhoFounder / CEOPedro Coelho worked as a strategy consultant advising pharmaceutical and biotech companies on clinical research operations before founding Biorce in 2024, an AI platform designed to streamline clinical trial development.
CB
Clara BernardesFounder
DP
Diogo PisoeiroFounder
JF
Jose FariaFounder

Investors · 9

Also in the syndicate · 1

DST Global Partnerslead

Funding

SEC filings, press & company announcements

$52.5M disclosed across 1 of 3 rounds · 2025–2026

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does Biorce do?
Aika is an operating system that uses AI and automation to orchestrate clinical trial development end-to-end, helping organizations accelerate protocol creation, prevent amendments, and interpret complex datasets across all stages of trial development.
Who founded Biorce?
Biorce was founded by Pedro Coelho.
Who are Biorce's investors?
Biorce's investors include Endeavor Catalyst, MSM, Plug and Play Ventures, YZR Capital, Masia, Mustard Seed Maze, Norrsken Accelerator, Norrsken VC.
How much funding has Biorce raised?
Biorce has disclosed $52.5M raised across 1 of its 3 known rounds.